AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Russian patent published in 2003 - IPC

Abstract RU 2220142 C2

FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to compounds of the formula (I): wherein Ar1 means heterocyclic group representing pyrazole that can be substituted with one or some radicals R1,R2 or R3; Ar2 means phenyl, naphthyl or tetrahydronaphthyl being each of them is substituted optionally with one-three groups R2; L means saturated or unsaturated branched or linear carbon C1-C10-chain wherein one or some methylene groups are replaced optionally with oxygen atom, NH or sulfur atom and wherein a binding group is substituted optionally with 0-2 oxo-groups; Q has values taken among the order: (a) phenyl, naphthyl, pyridine, imidazole, pyrane and so on; (b) tetrahydropyrane, morpholine, thiomorpholine, thiomorpholine sulfoxide and so on; (c) secondary or tertiary amino-group wherein nitrogen atom of amino-group is bound covalently with groups taken among C1-C3-alkyl, and C1-C5-alkoxyalkyl; R1 has values taken among the row: (a) branched or linear C3-C10-alkyl and so on; (b) C3-C7-cycloalkyl and so on, or tetrahydropyrane group; R2 represents branched or linear C1-C6-alkyl that can be halogenated partially or completely; R3 is taken among the row including: (a) phenyl, naphthyl and heterocyclic group representing pyridinyl and so on; (b) branched or linear (C1-C6)-alkyl that can be halogenated partially or completely and that can be substituted with phenyl group; R4 and R5 mean morpholine; X means oxygen atom; and to their physiologically acceptable salts and acids. Invention proposes method for preparing compounds of the formula (I). Also, invention proposes pharmaceutical composition inhibiting producing cytokines comprising compound by cl. 1 or its pharmaceutically acceptable derivatives as an active substance and usual adjuvants. Invention proposes methods for treatment of inflammatory and autoimmune disease that involve administration to patient needing treatment compound by cl. 1 taken in therapeutically effective amount. Invention provides preparing aromatic heterocyclic compounds as anti- -inflammatory agents. EFFECT: valuable medicinal properties of compounds. 17 cl, 16 sch, 3 tbl, 57 ex

Similar patents RU2220142C2

Title Year Author Number
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND METHOD FOR TREATMENT OF CYTOKINE-MEDIATED DISEASE 2000
  • Betageri Radzhashekhar
  • Brejtfelder Steffen
  • Sirillo Pier F.
  • Dzhilmor Tomas A.
  • Khikej Judzhin R.
  • Kirrejn Tomas M.
  • Moriak Monika
  • Moss Nil
  • Patel Usha R.
  • Praudfut Dzhon R.
  • Regan Dzhon R.
  • Sharma Radzhiv
  • San Sanksin
  • Svinamer Alan D.
  • Takakhashi Khidenori
RU2298008C2
COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS 2000
  • Betageri Radzhashekhar
  • Brejtfelder Steffen
  • Sirillo Pier F.
  • Dzhilmor Tomas A.
  • Khikej Judzhin R.
  • Kirrejn Tomas M.
  • Moriak Monika
  • Moss Nil
  • Patel Usha R.
  • Praudfut Dzhon R.
  • Regan Dzhon R.
  • Sharma Radzhiv
  • San Sanksin
  • Svinamer Alan D.
  • Takakhashi Khidenori
RU2242474C2
DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL-UREA AND THEIR USE IN TREATMENT, INTER ALIA, DISEASES OF RESPIRATORY TRACT 2011
  • Finch Harry
  • Van Niel Monique Bodil
  • Woo Chi-Kit
RU2586333C1
KINASE INHIBITORS 2012
  • Van Niel Monique Bodil
  • Ray Nicholas Charles
  • Alcaraz Lilian
  • Panchal Terry Aaron
  • Jennings Andrew Stephen Robert
  • Armani Elisabetta
  • Cridland Andrew Peter
  • Hurley Christopher
RU2623734C9
IMMUNOMODULATORY AZALIDES BASED ON UREA 2021
  • Cox Mark R.
  • Stuk Timothy L.
  • Maddux Todd M.
  • Ewin Richard Andrew
  • Johnson Paul D.
  • Respondek Tomasz
  • Kyne Graham M.
  • Vairagoundar, Rajendran
RU2811591C1
NEW PHTHALAZINONE DERIVATIVES AS AURORA A KINASE INHIBITORS 2005
  • Bojd Ehduard
  • Brukfild Frederik
  • Zhorzh Gi
  • Goller Bernkhard
  • Khjunsh Zabine
  • Rjuger Petra
  • Rjut Mattias
  • Shajblikh Shtefan
  • Shjull' Kristine
  • Fon-Der-Zal Vol'Fgang
  • Uorn Dzhastin
  • Vajgand Shtefan
RU2397166C2
COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS 2005
  • Lju Khon
  • Khe Sjaosjuj
  • Choj Kha-Sun
  • Jan Kunun
  • Vudmansi Dejvid
  • Van Chzhichehn
  • Ehllis Dejvid Archer
  • Vu Baogehn'
  • Khe En
  • Ngujen Trak Ngok
RU2431635C2
UREA COMPOUND, A METHOD FOR PRODUCTION THEREOF AND MEDICAL USE THEREOF 2017
  • Sy Tszyujtun
  • Tszyan Mejfen
RU2741596C2
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER 2015
  • Okhtake Esikhito
  • Okamoto Naoki
  • Ono Esiyuki
  • Kasivagi Khirotaka
  • Kimbara Atsusi
  • Kharada Takeo
  • Khori Nobuyuki
  • Murata Esikhisa
  • Tatibana Kadzutaka
  • Tanaka Sota
  • Nomura Keniti
  • Ide Mitsuaki
  • Midzuguti Ejsaku
  • Itida Yasukhiro
  • Okhtomo Suiti
  • Khoriba Naosi
RU2740008C2
NEW ANTICHOLINERGIC PREPARATIONS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS PHARMACEUTICALS 2003
  • Shpek Georg
  • Ajkkmajer Kristian
  • Pestel' Zabine
  • Germejer Zabine
  • Piper Mikhaehl' P.
  • Brajtfel'Der Shteffen
  • Grajurt Mattias
RU2325388C2

RU 2 220 142 C2

Authors

Kirillo Pir F.

Gilmor Tomas A.

Khiki Judzhin R.

Regan Dzhon R.

Chzhan Lin'Khua

Dates

2003-12-27Published

1999-12-09Filed